1. Home
  2. SNDL vs ALT Comparison

SNDL vs ALT Comparison

Compare SNDL & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDL
  • ALT
  • Stock Information
  • Founded
  • SNDL 2006
  • ALT 1997
  • Country
  • SNDL Canada
  • ALT United States
  • Employees
  • SNDL N/A
  • ALT N/A
  • Industry
  • SNDL Pharmaceuticals and Biotechnology
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNDL Health Care
  • ALT Health Care
  • Exchange
  • SNDL Nasdaq
  • ALT Nasdaq
  • Market Cap
  • SNDL 651.1M
  • ALT 292.0M
  • IPO Year
  • SNDL 2019
  • ALT N/A
  • Fundamental
  • Price
  • SNDL $2.68
  • ALT $3.83
  • Analyst Decision
  • SNDL
  • ALT Strong Buy
  • Analyst Count
  • SNDL 0
  • ALT 6
  • Target Price
  • SNDL N/A
  • ALT $17.40
  • AVG Volume (30 Days)
  • SNDL 4.9M
  • ALT 3.0M
  • Earning Date
  • SNDL 07-31-2025
  • ALT 08-12-2025
  • Dividend Yield
  • SNDL N/A
  • ALT N/A
  • EPS Growth
  • SNDL N/A
  • ALT N/A
  • EPS
  • SNDL N/A
  • ALT N/A
  • Revenue
  • SNDL $692,339,389.00
  • ALT $20,000.00
  • Revenue This Year
  • SNDL $5.52
  • ALT N/A
  • Revenue Next Year
  • SNDL $4.09
  • ALT $761,880.20
  • P/E Ratio
  • SNDL N/A
  • ALT N/A
  • Revenue Growth
  • SNDL 3.54
  • ALT N/A
  • 52 Week Low
  • SNDL $1.15
  • ALT $2.90
  • 52 Week High
  • SNDL $2.74
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • SNDL 82.41
  • ALT 51.79
  • Support Level
  • SNDL $2.07
  • ALT $3.35
  • Resistance Level
  • SNDL $2.74
  • ALT $3.66
  • Average True Range (ATR)
  • SNDL 0.14
  • ALT 0.19
  • MACD
  • SNDL 0.05
  • ALT 0.07
  • Stochastic Oscillator
  • SNDL 92.50
  • ALT 86.18

About SNDL SNDL Inc.

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: